Name: Extractables and Leachables Testing Market Size 2035
Creator: Roots Analysis
Published: 2026-10-26T00:00:01+05:30
License: https://www.rootsanalysis.com/terms.html
Keywords: Extractables and Leachables Testing Market, Extractables and Leachables Testing Market Growth, Extractables and Leachables Testing Market Trends, Extractables and Leachables Testing Market Size, Extractables and Leachables Testing Market Share, Extractables and Leachables Testing Market Analysis, Extractables and Leachables Testing Market Forecast, Extractables and Leachables Testing Market Report, Global Extractables and Leachables Testing Market, Extractables and Leachables Testing Industry

Extractables and Leachables Testing Market Outlook: USD 2,501 Million by 2035 at a CAGR of 10.6%

The global extractables and leachables testing market, valued at USD 908 million in 2025, is projected to reach USD 1,009 million in 2026 and USD 2,501 million by 2035, representing a CAGR of 10.6% during the forecast period 2026 to 2035. This growth is supported by the increasing regulatory emphasis on patient safety, product quality, expanding use of polymer-based materials and single-use systems in pharmaceutical manufacturing, and rising development of biologics, injectable products, combination products and advanced drug-delivery systems.

Global Extractables and Leachables Testing Market Growth 2025 to 2035

See What's in the Full Report – Request Your Complimentary Insights!

Market Report: Key Takeaways

Market Size & Trends

Container / closures and packaging materials currently account for the largest share of the extractables and leachables testing market.
Among the type of technique used, chromatography currently accounts for the largest market revenue, reflecting its central role in separating and characterizing organic extractables and leachables before mass-spectrometric identification and quantification.
Large companies capture the highest share of the extractables and leachables testing market size, and market momentum will likely sustain this trend through the forecast period.
By application, parenteral drug products hold the highest share (90%) of the global extractables and leachables testing market.
Europe currently captures more than 35% of the market, while Asia-Pacific is expected to register the fastest growth during the forecast period.

Key Market Statistics

Market Size in 2026: $1,009 Million
Estimated Market Size in 2035: $2,501 Million
CAGR (2026-2035): 10.6%
Europe: Largest market in 2026
Asia-Pacific: Fastest growing region

What Are Extractables and Leachables, and Why Is Testing Important?

Extractables are chemical species that can be released from a material or component under deliberately exaggerated laboratory conditions, whereas leachables are substances that migrate into a drug product under normal or simulated conditions of manufacture, storage and use. E&L testing is therefore used to identify, characterize and assess chemical substances originating from pharmaceutical packaging, container-closure systems, processing equipment, medical devices and drug-delivery systems.

The testing scope has expanded beyond conventional container-closure assessments as pharmaceutical and biopharmaceutical manufacturers adopt more polymer-based components, single-use bioprocess systems and complex delivery formats. Potential sources can include plastics, elastomers, glass-contact components, coatings, adhesives, bags, tubing, filters, connectors and other product-contact materials. Drug-delivery systems such as prefilled syringes, autoinjectors, inhalers and infusion systems may also require chemical characterization depending on the product and regulatory pathway.

Because leachables can affect product quality and may create patient-safety risks, study design must consider material composition, route of administration, duration of contact, sterilization or processing conditions, expected patient exposure and the sensitivity of the drug product matrix. This is particularly important for parenteral, ophthalmic and inhalation products, where exposure routes and formulation sensitivity can increase the scrutiny applied to E&L assessment.

Extractables and Leachables Testing Market Overview

The market opportunity for extractables and leachables testing service providers is likely to significantly rise in the coming decade. Rising adoption of pharmaceutical and biopharmaceutical products fuels this growth, primarily by intensifying the need to evaluate potential interactions between drug products and their associated container closure systems, packaging materials, and manufacturing components. Demand is also being reinforced by the wider use of single-use systems, biologics, combination products and specialized delivery devices that introduce additional material-contact interfaces across development, manufacturing, storage and administration.

While some large pharmaceutical and biopharmaceutical companies maintain internal analytical capabilities, comprehensive E&L programs often require specialized scientific expertise, high-sensitivity instrumentation, toxicological risk assessment, method development and validation, and traceable documentation. Outsourcing to specialized laboratories can therefore provide access to technical expertise and analytical infrastructure without requiring every drug developer or CMO / CDMO to build dedicated in-house capacity.

For service providers, differentiation increasingly depends on the ability to support the full study lifecycle - from material-risk assessment and extraction-study design through non-targeted screening, targeted leachables testing, compound identification, toxicological evaluation, method verification / validation and regulatory-ready reporting.

Scope, Methodology and Industry Expert Interviews

The findings in this report were developed through a structured methodology combining secondary research, proprietary databases and primary stakeholder interviews. Secondary research included company disclosures, regulatory information, facility and capacity announcements, scientific and technical literature, partnership activity and other publicly available market evidence. The research team triangulated findings across market sizing, segmentation, analytical technology adoption, outsourcing activity, regulatory expectations, company capabilities and regional trends before finalizing the analysis.

Emphasizing the recent advancements in extractables and leachables testing market, Tarja Nurmi, (Senior Expert, Extractables & Leachables, at Bayer R&D Pharmaceutical Sciences), stated, "Health authorities have recently paid a lot of attention to chemical safety of processes. Therefore, this is an E&L topic which the industry is working on at present."

The market report includes the transcripts from the following primary calls:

Former Commercial Development Manager of Biotechnology, Large Organization, US
Former Senior Study Manager, Large Organization, UK
Former Director, Analytical Services, Mid-sized Organization, US
President, Analytical Services, Small Organization, US

In addition, the market report includes transcripts of the following third-party discussions:

Associate Principal Scientist, Large Organization, US
Chief Scientific Officer, Mid-sized Organization, US
Scientific director, E&L Expert, Large Organization, US
Senior Expert, Extractables & Leachables, Very Large Organization, Germany
Principal Scientist, Very Large Organization, Germany
Director of Sales and Marketing, Small Organization, US

How is the Extractables and Leachables Testing Market Segmented?

Based on the research, the extractables and leachables testing market is segmented by type of container / device tested, type of technique used, company size, application, and geographical regions. This segmentation enables pharmaceutical and biopharmaceutical companies, CMO / CDMO business development teams, procurement and technical-operation teams, quality and regulatory professionals, investors and other market participants to assess the opportunity most relevant to their strategic requirements.

By Type of Container / Device Tested: Container / Closures and Packaging Materials, Medical Devices, Single Use Systems and Processing Equipment, and Other Components
By Type of Technique Used: Chromatography, Spectroscopy, and Other Techniques
By Company Size: Large Companies, Mid-sized Companies, and Small Companies

By Application: Parenteral Drug Products, Inhalation Drug Products, and Oral Solutions and Suspensions

By Geographical Regions: North America (US and Canada), Europe (Germany, Italy, France, UK, Spain, and Rest of Europe), Asia-Pacific (India, China, Japan, and Rest of Asia-Pacific), Latin America (Brazil, Argentina), Middle East and Africa (South Africa, Bahrain, Saudi Arabia, and Israel)

Pay Only for What You Need – The Best Way to Optimize

Extractables and Leachables Testing Market Key Insights

What are the Key Drivers of Extractables and Leachables Testing Industry Growth?

Evolving Regulatory Requirements: Regulatory expectations are increasing the need for systematic E&L assessment across packaging, manufacturing systems and drug-delivery components. The draft ICH Q3E guideline introduces a harmonized, risk-based framework for the assessment and control of leachables, while USP chapters <1663> and <1664> provide established frameworks for extractables and drug-product leachables. USP <665>, which became official in May 2026, further strengthens expectations for plastic components and systems used in pharmaceutical and biopharmaceutical manufacturing. These developments are increasing demand for defensible study design, analytical sensitivity, toxicological risk assessment and lifecycle control strategies.
Growing Use of Single-Use Systems: The rising adoption of disposable bags, tubing, filters, connectors and other polymer-based components in biopharmaceutical manufacturing is increasing the number of product-contact materials that may require extractables characterization. This is supporting demand for risk-based E&L studies that evaluate material compatibility, process exposure and patient-safety implications while also supporting the contamination-control benefits of single-use manufacturing.
Expansion of Biologics, Parenteral Products and Combination Products: Growth in biologics and sensitive injectable products increases the importance of understanding low-level chemical migration from containers, closures, delivery devices and processing equipment. Combination products and advanced drug-delivery formats can add interfaces involving syringes, autoinjectors, inhalers or other device components, further increasing the need for integrated material and product testing.

What are the Main Challenges in Extractables and Leachables Testing?

High Cost and Resource Intensity: E&L testing requires specialized scientific instruments, skilled analytical professionals, validated methods and extensive laboratory resources. Multiple extraction conditions, non-targeted screening, compound identification, targeted quantification and toxicological assessment can increase project cost and turnaround time, particularly for smaller companies without dedicated in-house capability.
Complex Drug-Product Matrices: Complex drug-product matrices present a major challenge because proteins, lipids, surfactants and excipients can interfere with the detection and quantification of trace-level chemical compounds. Matrix effects may suppress or amplify analytical signals, obscure low-level leachables and complicate compound identification, requiring product-specific sample preparation and analytical strategies.
Unknown Compounds and Changing Material Profiles: Changes in suppliers, polymer formulations, coatings, sterilization methods or manufacturing conditions can alter extractables profiles over time. Laboratories therefore need robust unknown-identification workflows, change-control strategies and sufficient historical data to determine when bridging studies or repeat testing are scientifically justified.

How Are Regulatory Expectations for E&L Testing Evolving?

Regulatory convergence is increasing around a risk-based, lifecycle approach to E&L assessment. ICH Q3E was endorsed at Step 2 in August 2025 and, as of 2026, remains a draft guideline under the ICH process. The FDA issued draft Q3E guidance in November 2025, while the EMA consultation on the draft opened in August 2025 and subsequently closed. The framework emphasizes assessment and control of leachables to protect patient safety and pharmaceutical product quality.

Alongside ICH Q3E, USP <1663> and <1664> remain important scientific frameworks for extractables and leachables associated with pharmaceutical packaging and delivery systems. USP <665>, official from May 1, 2026, is especially relevant to plastic components and systems used in pharmaceutical and biopharmaceutical manufacturing. For medical-device applications, chemical characterization may also intersect with ISO 10993-18 and toxicological risk assessment requirements, depending on the device and regulatory pathway.

For testing service providers, these developments increase the value of scientifically justified study designs, qualified analytical methods, data integrity, clear documentation and audit-ready reporting that can support regulatory submissions across multiple regions.

Recent Developments in Extractables and Leachables Testing Market

In May 2026, USP General Chapter <665> became official, providing an informational framework for assessing plastic components and systems used in pharmaceutical and biopharmaceutical manufacturing.
In February 2026, Scientech Laboratories reported that it had added mass spectrometry and microbiology laboratories, expanding its product-safety testing capabilities. Its mass spectrometry platform supports extractables and leachables testing alongside other impurity analyses.
In February 2026, the ICH Q3E Expert Working Group published its work plan and began addressing public-consultation comments on the draft Extractables and Leachables guideline. The program moves toward a harmonized framework for assessing and controlling E&L impurities in pharmaceutical products.

Your Business is Unique – Why Shouldn't Your Report Be?

Extractables and Leachables Testing Market Share Insights

Which Type of Container / Device Tested Accounts for the Largest Share?

Container / closures and packaging materials currently account for the majority share of the extractables and leachables testing market. This reflects their direct role in protecting pharmaceutical products throughout storage and use and the need to evaluate compatibility, stability and patient-safety risks associated with product-contact materials. Single use systems and processing equipment segment is likely to grow at a relatively faster pace, primarily driven by the increasing adoption of single-use technologies in biopharmaceutical manufacturing.

Which Type of Technique Used Accounts for the Largest Share in the Extractables and Leachables Testing Market?

Chromatography currently accounts for 60% of market revenue, supported by its established role in separating complex mixtures before identification and quantification of organic extractables and leachables. The spectroscopy segment is expected to grow at a healthy CAGR of 10.3% throughout the forecast period.

Which Company Size Holds the Largest Share in the Extractables and Leachables Testing Market?

Large companies currently account for the largest share, reflecting the capital-intensive analytical infrastructure, scientific expertise, quality systems and regulatory capabilities required to execute comprehensive E&L programs. Small companies are expected to grow faster, at a CAGR of 12.6%, as specialized laboratories compete on technical depth, flexibility, turnaround time and niche analytical capabilities.

Which Application Accounts for the Largest Share?

Parenteral drug products currently account for the largest application share, at 90%. Because these products bypass many of the body's protective barriers, leachables associated with container-closure systems, syringes, elastomeric components, infusion-related components and manufacturing systems can receive particularly close scrutiny. Ophthalmic and inhalation products also require product-specific assessment because of route-of-administration sensitivity and the complexity of their packaging and delivery systems.

Global Extractables and Leachables Testing Market Size by Application, 2026 and 2035

Regional Analysis

Why Does Europe Hold the Largest Share of the Extractables and Leachables Testing Market?

Europe currently captures more than 35% of the global market, supported by its established pharmaceutical and biopharmaceutical manufacturing base, concentration of specialized analytical laboratories, and strong regulatory focus on pharmaceutical quality and patient safety. Asia-Pacific is expected to register the fastest growth during the forecast period as pharmaceutical manufacturing, outsourcing activity and investment in analytical-testing infrastructure expand across the region.

Global Extractables and Leachables Testing Market Outlook by Geographical Regions, 2026

Get an Instant Quote in 10 Minutes. Lowest Price Guaranteed

Key Players in the Extractables and Leachables Testing Market

The report profiles Agilent Technologies, ALS Pharmaceutical, Cytiva, Element Materials Technology, Eurofins Scientific, Intertek Group, PPD (Part of Thermo Fisher Scientific), Sartorius, SGS, and WuXi AppTec. A complete list of close to 130 companies captured is available within the full report. Company references are included for independent market analysis and benchmarking and do not imply endorsement, sponsorship or a commercial relationship with Roots Analysis.

Report Deliverables and Customization

Alongside the core market report, clients receive complimentary Excel data packs covering the extractables and leachables testing market landscape, company competitiveness analysis, recent acquisitions, and market sizing and opportunity analysis. The package also includes a complimentary PowerPoint presentation summarizing the full report, and we offer a 15% free customization scope on request. The report is designed to support pharmaceutical and biopharmaceutical business-development teams, procurement and technical-operations functions, R&D teams, quality and regulatory professionals, CMO / CDMO leadership, investors and other decision-makers evaluating outsourcing partners, analytical capabilities, testing capacity, regulatory readiness and regional expansion opportunities.

Report Authorship

Author(s): This report was co-authored by Rupali Vadhera and Simriti Gupta, both part of Roots Analysis's healthcare and pharma research practice, covering biologics discovery, development, and manufacturing market studies. All findings are based on proprietary databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.

Independence and Non-Affiliation

Roots Analysis is an independent market research and consulting firm. This report draws on publicly available information, primary interviews and proprietary analysis. Roots Analysis is not affiliated with, endorsed by or acting on behalf of the FDA, the European Medicines Agency, any pharmaceutical or biopharmaceutical company, CMO / CDMO, testing laboratory, branded product or individual named in this report. Company and product names are referenced solely for factual, market-analysis and benchmarking purposes.

This report represents the second edition of an ongoing research series tracking the extractables and leachables testing market. Roots Analysis maintains an independent primary-research process and does not receive compensation from companies profiled in the report in exchange for inclusion or favorable characterization.

+ 1. PREFACE

1.1. Introduction

1.2. Market Share Insights

1.3. Report Coverage

1.4. Key Questions Answered

+ 2. RESEARCH METHODOLOGY

2.1. Chapter Overview

2.2. Research Assumptions

2.2.1. Market Landscape and Market Trends

2.2.2. Market Forecast and Opportunity Analysis

2.2.3. Comparative Analysis

2.3. Database Building

2.3.1. Data Collection

2.3.2. Data Validation

2.3.3. Data Analysis

2.4. Project Methodology

2.4.1. Secondary Research

2.4.1.1. Annual Reports

2.4.1.2. Academic Research Papers

2.4.1.3. Company Websites

2.4.1.4. Investor Presentations

2.4.1.5. Regulatory Filings

2.4.1.6. White Papers

2.4.1.7. Industry Publications

2.4.1.8. Conferences and Seminars

2.4.1.9. Government Portals

2.4.1.10. Media and Press Releases

2.4.1.11. Newsletters

2.4.1.12. Industry Databases

2.4.1.13. Roots Proprietary Databases

2.4.1.14. Paid Databases and Sources

2.4.1.15. Social Media Portals

2.4.1.16. Other Secondary Sources

2.4.2. Primary Research

2.4.2.1. Types of Primary Research

2.4.2.1.1. Qualitative Research

2.4.2.1.2. Quantitative Research

2.4.2.1.3. Hybrid Approach

2.4.2.2. Advantages of Primary Research

2.4.2.3. Techniques for Primary Research

2.4.2.3.1. Interviews

2.4.2.3.2. Surveys

2.4.2.3.3. Focus Groups

2.4.2.3.4. Observational Research

2.4.2.3.5. Social Media Interactions

2.4.2.4. Key Opinion Leaders Considered in Primary Research

2.4.2.4.1. Company Executives (CXOs)

2.4.2.4.2. Board of Directors

2.4.2.4.3. Company Presidents and Vice Presidents

2.4.2.4.4. Research and Development Heads

2.4.2.4.5. Technical Experts

2.4.2.4.6. Subject Matter Experts

2.4.2.4.7. Scientists

2.4.2.4.8. Doctors and Other Healthcare Providers

2.4.2.5. Ethics and Integrity

2.4.2.5.1. Research Ethics

2.4.2.5.2. Data Integrity

2.4.3. Analytical Tools and Databases

2.5. Robust Quality Control

+ 3. MARKET DYNAMICS

3.1. Chapter Overview

3.2. Forecast Methodology

3.2.1. Top-down Approach

3.2.2. Bottom-up Approach

3.2.3. Hybrid Approach

3.3. Market Assessment Framework

3.3.1. Total Addressable Market (TAM)

3.3.2. Serviceable Addressable Market (SAM)

3.3.3. Serviceable Obtainable Market (SOM)

3.3.4. Currently Acquired Market (CAM)

3.4. Forecasting Tools and Techniques

3.4.1. Qualitative Forecasting

3.4.2. Correlation

3.4.3. Regression

3.4.4. Extrapolation

3.4.5. Convergence

3.4.6. Sensitivity Analysis

3.4.7. Scenario Planning

3.4.8. Data Visualization

3.4.9. Time Series Analysis

3.4.10. Forecast Error Analysis

3.5. Key Considerations

3.5.1. Demographics

3.5.2. Government Regulations

3.5.3. Reimbursement Scenarios

3.5.4. Market Access

3.5.5. Supply Chain

3.5.6. Industry Consolidation

3.5.7. Pandemic / Unforeseen Disruptions Impact

3.6. Limitations

+ 4. MACRO-ECONOMIC INDICATORS

4.1. Chapter Overview

4.2. Market Dynamics

4.2.1. Time Period

4.2.1.1. Historical Trends

4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage

4.2.2.1. Major Currencies Affecting the Market

4.2.2.2. Factors Affecting Currency Fluctuations

4.2.2.3. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Currency Exchange Rate

4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market

4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession

4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt

4.2.5. Inflation

4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy

4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates

4.2.6.1. Interest Rates and Their Impact on the Market

4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis

4.2.7.1. Type of Commodity

4.2.7.2. Origins and Destinations

4.2.7.3. Value and Weights

4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics

4.2.8.1. Import Scenario

4.2.8.2. Export Scenario

4.2.8.3. Trade Policies

4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers

4.2.8.5. Impact of Trade Barriers on the Market

4.2.9. War Impact Analysis

4.2.9.1. Russian-Ukraine War

4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors

4.2.10.1. Global Economic Impact

4.2.10.2. Industry-specific Impact

4.2.10.3. Government Response and Stimulus Measures

4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators

4.2.11.1. Fiscal Policy

4.2.11.2. Consumer Spending

4.2.11.3. Gross Domestic Product (GDP)

4.2.11.4. Employment

4.2.11.5. Taxes

4.2.11.6. Stock Market Performance

4.2.11.7. Cross-Border Dynamics

4.3. Conclusion

+ 5. EXECUTIVE SUMMARY

5.1. Chapter Overview

5.2. Executive Summary: Market Landscape

5.3. Executive Summary: Market Trends

5.4. Executive Summary: Market Sizing and Opportunity Analysis

+ 6. INTRODUCTION

6.1. Chapter Overview

6.2. Significance of Extractables and Leachables Testing

6.2.1. Extractables Testing

6.2.2. Leachables Testing

6.3. Stages of Extractables and Leachables Testing

6.3.1. Sample Assessment

6.3.2. Extraction of Potential Impurities under Vigorous Conditions

6.3.3. Analysis of Extracts

6.3.4. Assessment of Extractables Data

6.3.5. Conducting Leachables Study

6.4. Identification of Extractables and Leachables

6.5. Detection of Organic Compounds

6.6. Detection of Inorganic Compounds

6.7. Quality Consideration in an Extractables and Leachables Study

6.8. Regulatory Guidelines for Extractables and Leachables Assessment

6.9. Challenges Associated with Extractables and Leachables Testing

+ 7. MARKET LANDSCAPE

7.1. Chapter Overview

7.2. Extractables and Leachables Testing Service Providers: Overall Market Landscape

7.2.1. Analysis by Year of Establishment

7.2.2. Analysis by Company Size

7.2.3. Analysis by Location of Headquarters

7.2.4. Analysis by Type of Container / Device Tested

7.2.5. Analysis by Type of Technique Used

7.2.6. Analysis by Type of Chromatography Technique

7.2.7. Analysis by Type of Spectroscopy

7.2.8. Analysis by Application

+ 8. COMPANY COMPETITIVENESS ANALYSIS

8.1. Chapter Overview

8.2. Assumptions and Key Parameters

8.3. Methodology

8.4. Extractables and Leachables Testing Service Providers: Company Competitiveness Analysis

8.4.1. Extractables and Leachables Testing Service Providers based in North America (Peer Group I)

8.4.2. Extractables and Leachables Testing Service Providers based in Europe (Peer Group II)

8.4.3. Extractables and Leachables Testing Service Providers based in Asia-Pacific and Rest of the World (Peer Group III)

+ 9. COMPANY PROFILES: EXTRACTABLES AND LEACHABLES TESTING SERVICE PROVIDERS IN NORTH AMERICA

9.1. Chapter Overview

9.2. Agilent Technologies

9.2.1. Company Overview

9.2.2. Financial Information

9.2.3. Recent Initiatives

9.2.4. Service Portfolio

9.3. Cytiva (Part of Danaher)

9.4. PPD (Part of Thermo Fisher Scientific)

+ 10. COMPANY PROFILES: EXTRACTABLES AND LEACHABLES TESTING SERVICE PROVIDERS IN EUROPE

10.1. Chapter Overview

10.2. Element Materials Technology

10.2.1. Company Overview

10.2.2. Financial Information

10.2.3. Recent Initiatives

10.2.4. Service Portfolio

10.3. Eurofins Scientific

10.4. Intertek Group

10.5. Sartorius

10.6. SGS

+ 11. COMPANY PROFILES: EXTRACTABLES AND LEACHABLES TESTING SERVICE PROVIDERS IN ASIA-PACIFIC

11.1. Chapter Overview

11.2. ALS Global

11.2.1. Company Overview

11.2.2. Financial Information

11.2.3. Recent Initiatives

11.2.4. Service Portfolio

11.3. WuXi AppTec

+ 12. RECENT ACQUISITIONS

12.1. Chapter Overview

12.2. Types of Acquisitions

12.3. Recent Acquisitions: Extractables and Leachables Testing Service Providers

12.3.1. Analysis by Year of Acquisition

12.3.2. Analysis by Type of Acquisition

12.3.3. Analysis by Year and Type of Acquisition

12.3.4. Analysis by Geography

12.3.4.1. Intercontinental and Intracontinental Deals

12.3.4.2. Local and International Deals

12.3.5. Most Active Players: Analysis by Number of Acquisitions

+ 13. GLOBAL EXTRACTABLES AND LEACHABLES TESTING SERVICES MARKET

13.1. Chapter Overview

13.2. Key Assumptions and Methodology

13.3. Global Extractables and Leachables Testing Services Market, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

13.3.1. Roots Analysis Perspective on Market Growth

13.3.2. Multivariate Scenario Analysis

13.3.2.1. Conservative Scenario

13.3.2.2. Optimistic Scenario

13.4. Key Market Segmentations

+ 14. EXTRACTABLES AND LEACHABLES TESTING SERVICES MARKET, BY TYPE OF CONTAINER / DEVICE TESTED

14.1. Chapter Overview

14.2. Key Assumptions and Methodology

14.3. Extractables and Leachables Testing Services Market: Distribution by Type of Container / Device Tested

14.3.1. Extractables and Leachables Testing Services Market for Container / Closures and Packaging Materials, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

14.3.2. Extractables and Leachables Testing Services Market for Medical Devices, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

14.3.3. Extractables and Leachables Testing Services Market for Single Use Systems and Processing Equipment, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

14.3.4. Extractables and Leachables Testing Services Market for Other Components, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

14.4. Data Triangulation and Validation

+ 15. EXTRACTABLES AND LEACHABLES TESTING SERVICES MARKET, BY TYPE OF TECHNIQUE USED

15.1. Chapter Overview

15.2. Key Assumptions and Methodology

15.3. Extractables and Leachables Testing Services Market: Distribution by Type of Technique Used

15.3.1. Extractables and Leachables Testing Services Market for Chromatography, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

15.3.2. Extractables and Leachables Testing Services Market for Spectroscopy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

15.3.3. Extractables and Leachables Testing Services Market for Other Techniques, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

15.4. Data Triangulation and Validation

+ 16. EXTRACTABLES AND LEACHABLES TESTING SERVICES MARKET, BY COMPANY SIZE

16.1. Chapter Overview

16.2. Key Assumptions and Methodology

16.3. Extractables and Leachables Testing Services Market: Distribution by Company Size

16.3.1. Extractables and Leachables Testing Services Market for Large Companies, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

16.3.2. Extractables and Leachables Testing Services Market for Mid-Sized Companies, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

16.3.3. Extractables and Leachables Testing Services Market for Small Companies, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

16.4. Data Triangulation and Validation

+ 17. EXTRACTABLES AND LEACHABLES TESTING SERVICES MARKET, BY APPLICATION

17.1. Chapter Overview

17.2. Key Assumptions and Methodology

17.3. Extractables and Leachables Testing Services Market: Distribution by Application

17.3.1. Extractables and Leachables Testing Services Market for Parenteral Drug Products, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

17.3.2. Extractables and Leachables Testing Services Market for Inhalation Drug Products, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

17.3.3. Extractables and Leachables Testing Services Market for Oral Solutions and Suspensions, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

17.4. Data Triangulation and Validation

+ 18. EXTRACTABLES AND LEACHABLES TESTING SERVICES MARKET BY GEOGRAPHICAL REGIONS

18.1. Chapter Overview

18.2. Key Assumptions and Methodology

18.3. Extractables and Leachables Testing Services Market: Distribution by Geographical Regions

18.3.1. Extractables and Leachables Testing Services Market in North America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.1.1. Extractables and Leachables Testing Services Market in the US, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.1.2. Extractables and Leachables Testing Services Market in Canada, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.2. Extractables and Leachables Testing Services Market in Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.2.1. Extractables and Leachables Testing Services Market in Germany, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.2.2. Extractables and Leachables Testing Services Market in Italy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.2.3. Extractables and Leachables Testing Services Market in France, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.2.4. Extractables and Leachables Testing Services Market in the UK, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.2.5. Extractables and Leachables Testing Services Market in Spain, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.2.6. Extractables and Leachables Testing Services Market in Rest of Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.3. Extractables and Leachables Testing Services Market in Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.3.1. Extractables and Leachables Testing Services Market in India, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.3.2. Extractables and Leachables Testing Services Market in China, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.3.3. Extractables and Leachables Testing Services Market in Japan, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.3.4. Extractables and Leachables Testing Services Market in Rest of Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.4. Extractables and Leachables Testing Services Market in Latin America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.4.1. Extractables and Leachables Testing Services Market in Brazil, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.4.2. Extractables and Leachables Testing Services Market in Argentina, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.5. Extractables and Leachables Testing Services Market in Middle East and Africa, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.5.1. Extractables and Leachables Testing Services Market in South Africa, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.5.2. Extractables and Leachables Testing Services Market in Bahrain, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.5.3. Extractables and Leachables Testing Services Market in Saudi Arabia, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.3.5.4. Extractables and Leachables Testing Services Market in Israel, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035)

18.4. Market Dynamics Assessment

18.4.1. Market Movement Analysis

18.4.2. Penetration-Growth (P-G) Matrix

18.5. Data Triangulation and Validation

+ 19. REGULATORY LANDSCAPE FOR EXTRACTABLES AND LEACHABLES

19.1. Chapter Overview

19.2. Safety Concerns for Extractables and Leachables in Final Drug Products

19.3. Guidelines Issued by Different Regulatory Authorities / Organizations

19.3.1. United States Food and Drug Administration (USFDA)

19.3.2. European Medicines Agency (EMA)

19.3.3. Health Canada

19.3.4. Product Quality Research Institute (PQRI)

19.3.5. Biophorum Operations Group (BPOG)

19.4. Risk-Based Approach to Extractables and Leachables Testing

19.5. Toxicological Assessments

19.6. Regulatory Considerations for Different Products

19.6.1. Single Use Systems

19.6.2. Biopharmaceuticals

19.6.3. Parenteral and Ophthalmic Drug Products (PODPs)

19.6.4. Electronic Nicotine Delivery Systems

+ 20. INTERVIEW TRANSCRIPTS

20.1. Chapter Overview

20.2. Company A

20.2.1. Company Snapshot

20.2.2. Interview Transcript: Former Commercial Development Manager of Biotechnology

20.3. Company B

20.3.1. Company Snapshot

20.3.2. Interview Transcript: Former Senior Study Manager

20.4. Company C

20.4.1. Company Snapshot

20.4.2. Interview Transcript: Former Director, Analytical Services

20.5. Company D

20.5.1. Company Snapshot

20.5.2. Interview Transcript: President, Analytical Services

+ 21. THIRD PARTY EXPERT DISCUSSION TRANSCRIPTS

21.1. Chapter Overview

21.2. Subathra Ramamoorthy on Extractables and Leachables in Bioanalysis: Key Insights and Best Practices

21.2.1. Third Party Expert Discussion Transcript

21.3. E&L Challenges in Biologics, Part One

21.3.1. Third Party Expert Discussion Transcript

21.4. Practical Consideration for Cumulative E&L Effects from Production Components

21.4.1. Third Party Expert Discussion Transcript

21.5. Exploring Extractable and Leachable Testing Strategies for Parenterals

21.5.1. Third Party Expert Discussion Transcript

21.6. Interview with Sartorius 2024

21.6.1. Third Party Expert Discussion Transcript

21.7. Study of Extractables and Leachables (E&L) – Interview

21.7.1. Third Party Expert Discussion Transcript

+ 22. CONCLUDING REMARKS

+ 23. APPENDIX I: TABULATED DATA

+ 24. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

+ List of Figures

Figure 2.1 Research Methodology: Project Methodology

Figure 2.2 Research Methodology: Data Sources for Secondary Research

Figure 2.3 Research Methodology: Robust Quality Control

Figure 3.1 Market Dynamics: Forecast Methodology

Figure 3.2 Market Dynamics: Market Assessment Framework

Figure 4.1 Lessons Learnt from Past Recessions

Figure 5.1 Executive Summary: Market Landscape

Figure 5.2 Executive Summary: Market Trends

Figure 5.3 Executive Summary: Market Sizing and Opportunity Analysis

Figure 6.1 Correlation Between Extractables and Leachables

Figure 6.2 Extractables and Leachables Testing: Types of Products Tested

Figure 6.3 Extractables and Leachables Testing: Steps Involved

Figure 6.4 Instrumentation used for Detecting Unknown Organic Compounds

Figure 6.5 Techniques used for Detecting Unknown Inorganic Compounds

Figure 6.6 Industry & Regulatory Guidance for Extractables and Leachables Evaluation

Figure 7.1 Extractables and Leachables Testing Service Providers: Distribution by Year of Establishment

Figure 7.2 Extractables and Leachables Testing Service Providers: Distribution by Company Size

Figure 7.3 Extractables and Leachables Testing Service Providers: Distribution by Location of Headquarters

Figure 7.4 Extractables and Leachables Testing Service Providers: Distribution by Type of Container / Device Tested

Figure 7.5 Extractables and Leachables Testing Service Providers: Distribution by Type of Technique Used

Figure 7.6 Extractables and Leachables Testing Service Providers: Distribution by Type of Chromatography Technique

Figure 7.7 Extractables and Leachables Testing Service Providers: Distribution by Type of Spectroscopy

Figure 7.8 Extractables and Leachables Testing Service Providers: Distribution by Application

Figure 8.1 Company Competitiveness Analysis: Extractables and Leachables Testing Service Providers based in North America (Peer Group I)

Figure 8.2 Company Competitiveness Analysis: Extractables and Leachables Testing Service Providers based in Europe (Peer Group II)

Figure 8.3 Company Competitiveness Analysis: Extractables and Leachables Testing Service Providers based in Asia-Pacific and Rest of the World (Peer Group III)

Figure 12.1 Recent Acquisitions: Cumulative Year-Wise Distribution, Since 2024

Figure 12.2 Recent Acquisitions: Distribution by Type of Acquisition

Figure 12.3 Recent Acquisitions: Distribution by Year and Type of Acquisition

Figure 12.4 Recent Acquisitions: Intercontinental and Intracontinental Deals

Figure 12.5 Recent Acquisitions: Distribution by Local and International Deals

Figure 12.6 Most Active Players: Analysis by Number of Acquisitions

Figure 13.1 Global Extractables and Leachables Testing Services Market, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 13.2 Global Extractables and Leachables Testing Services Market (Till 2035): Conservative Scenario (USD Million)

Figure 13.3 Global Extractables and Leachables Testing Services Market (Till 2035): Optimistic Scenario (USD Million)

Figure 14.1 Extractables and Leachables Testing Services Market: Distribution by Type of Container / Device Tested

Figure 14.2 Extractables and Leachables Testing Services Market for Container / Closures and Packaging Materials, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 14.3 Extractables and Leachables Testing Services Market for Medical Devices, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 14.4 Extractables and Leachables Testing Services Market for Single Use Systems and Processing Equipment, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 14.5 Extractables and Leachables Testing Services Market for Other Components, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 15.1 Extractables and Leachables Testing Services Market: Distribution by Type of Technique Used

Figure 15.2 Extractables and Leachables Testing Services Market for Chromatography, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 15.3 Extractables and Leachables Testing Services Market for Spectroscopy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 15.4 Extractables and Leachables Testing Services Market for Other Techniques, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 16.1 Extractables and Leachables Testing Services Market: Distribution by Company Size

Figure 16.2 Extractables and Leachables Testing Services Market for Large Companies, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 16.3 Extractables and Leachables Testing Services Market for Mid-Sized Companies, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 16.4 Extractables and Leachables Testing Services Market for Small Companies, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 17.1 Extractables and Leachables Testing Services Market: Distribution by Application

Figure 17.2 Extractables and Leachables Testing Services Market for Parenteral Drug Products, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 17.3 Extractables and Leachables Testing Services Market for Inhalation Drug Products, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 17.4 Extractables and Leachables Testing Services Market for Oral Solutions and Suspensions, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.1 Extractables and Leachables Testing Services Market: Distribution by Geographical Regions

Figure 18.2 Extractables and Leachables Testing Services Market in North America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.3 Extractables and Leachables Testing Services Market in the US, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.4 Extractables and Leachables Testing Services Market in Canada, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.5 Extractables and Leachables Testing Services Market in Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.6 Extractables and Leachables Testing Services Market in Germany, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.7 Extractables and Leachables Testing Services Market in Italy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.8 Extractables and Leachables Testing Services Market in France, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.9 Extractables and Leachables Testing Services Market in the UK, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.10 Extractables and Leachables Testing Services Market in Spain, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.11 Extractables and Leachables Testing Services Market in Rest of Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.12 Extractables and Leachables Testing Services Market in Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.13 Extractables and Leachables Testing Services Market in India, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.14 Extractables and Leachables Testing Services Market in China, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.15 Extractables and Leachables Testing Services Market in Japan, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.16 Extractables and Leachables Testing Services Market in Rest of Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.17 Extractables and Leachables Testing Services Market in Latin America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.18 Extractables and Leachables Testing Services Market in Brazil, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.19 Extractables and Leachables Testing Services Market in Argentina, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.20 Extractables and Leachables Testing Services Market in Middle East and Africa, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.21 Extractables and Leachables Testing Services Market in South Africa, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.22 Extractables and Leachables Testing Services Market in Bahrain, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.23 Extractables and Leachables Testing Services Market in Saudi Arabia, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.24 Extractables and Leachables Testing Services Market in Israel, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Figure 18.25 Market Movement Analysis: Geographical Regions

Figure 18.26 Penetration-Growth (P-G) Matrix: Geographical Regions

Figure 19.1 Considerations for Evaluation of Extractables and Leachables in Parenteral Products

Figure 19.2 Risk-Based Approach for Extractable and Leachables Testing

Figure 19.3 Decision Tree for Extractables and Leachables Testing of Single-use Systems

Figure 22.1 Concluding Remarks: Extractables and Leachables Testing Service Providers Market Landscape

Figure 22.2 Concluding Remarks: Recent Acquisitions

Figure 22.3 Concluding Remarks: Market Forecast and Opportunity Analysis

+ List of Tables

Table 6.1 Physical and Chemical Characteristics of Leachable Impurities

Table 6.2 Pharmaceutical Products / Components: Leachables Impurities Risk

Table 6.3 Common Isolation and Preparation Techniques

Table 6.4 Volatile Organic Impurities: Threshold Levels (USP 467)

Table 6.5 Limits for Elemental Impurities based on Route of Administration

Table 7.1 Extractables and Leachables Testing Service Providers: Information on Year of Establishment, Company Size, Location of Headquarters, and Type of Container / Device Tested

Table 7.2 Extractables and Leachables Testing Service Providers: Information on Type of Technique Used and Type of Chromatography Technique

Table 7.3 Extractables and Leachables Testing Service Providers: Information on Type of Spectroscopy and Application

Table 9.1 Extractables and Leachables Testing Service Providers in North America: List of Companies Profiled

Table 9.2 Agilent Technologies: Company Overview

Table 9.3 Agilent Technologies: Service Portfolio

Table 9.4 Cytiva (Part of Danaher): Company Overview

Table 9.5 Cytiva (Part of Danaher): Service Portfolio

Table 9.6 PPD (Part of Thermo Fisher Scientific): Company Overview

Table 9.7 PPD (Part of Thermo Fisher Scientific): Service Portfolio

Table 10.1 Extractables and Leachables Testing Service Providers in Europe: List of Companies Profiled

Table 10.2 Element Materials Technology: Company Overview

Table 10.3 Element Materials Technology: Service Portfolio

Table 10.4 Eurofins Scientific: Company Overview

Table 10.5 Eurofins Scientific: Service Portfolio

Table 10.6 Intertek Group: Company Overview

Table 10.7 Intertek Group: Service Portfolio

Table 10.8 Sartorius: Company Overview

Table 10.9 Sartorius: Service Portfolio

Table 10.10 SGS: Company Overview

Table 10.11 SGS: Service Portfolio

Table 11.1 Extractables and Leachables Testing Service Providers in Asia-Pacific: List of Companies Profiled

Table 11.2 ALS Global: Company Overview

Table 11.3 ALS Global: Service Portfolio

Table 11.4 WuXi AppTec: Company Overview

Table 11.5 WuXi AppTec: Service Portfolio

Table 12.1 Extractables and Leachables Testing Service Providers: List of Acquisitions, Since 2024

Table 19.1 Factors Influencing Safety Assessment of Final Products

Table 19.2 Safety Classification of Extractables / Leachables Proposed by PQRI

Table 20.1 Company A: Company Snapshot

Table 20.2 Company B: Company Snapshot

Table 20.3 Company C: Company Snapshot

Table 20.4 Company D: Company Snapshot

Table 23.1 Extractables and Leachables Testing Service Providers: Distribution by Year of Establishment

Table 23.2 Extractables and Leachables Testing Service Providers: Distribution by Company Size

Table 23.3 Extractables and Leachables Testing Service Providers: Distribution by Location of Headquarters

Table 23.4 Extractables and Leachables Testing Service Providers: Distribution by Type of Container / Device Tested

Table 23.5 Extractables and Leachables Testing Service Providers: Distribution by Type of Technique Used

Table 23.6 Extractables and Leachables Testing Service Providers: Distribution by Type of Chromatography Technique

Table 23.7 Extractables and Leachables Testing Service Providers: Distribution by Type of Spectroscopy

Table 23.8 Extractables and Leachables Testing Service Providers: Distribution by Application

Table 23.9 Recent Acquisitions: Cumulative Year-Wise Distribution, Since 2024

Table 23.10 Recent Acquisitions: Distribution by Type of Acquisition

Table 23.11 Recent Acquisitions: Distribution by Year and Type of Acquisition

Table 23.12 Most Active Players: Analysis by Number of Acquisitions

Table 23.13 Recent Acquisitions: Distribution by Local and International Deals

Table 23.14 Recent Acquisitions: Intracontinental and Intercontinental Deals

Table 23.15 Global Extractables and Leachables Testing Services Market, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.16 Global Extractables and Leachables Testing Services Market (Till 2035): Conservative Scenario (USD Million)

Table 23.17 Global Extractables and Leachables Testing Services Market (Till 2035): Optimistic Scenario (USD Million)

Table 23.18 Extractables and Leachables Testing Services Market: Distribution by Type of Container / Device Tested

Table 23.19 Extractables and Leachables Testing Services Market for Container / Closures and Packaging Materials, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.20 Extractables and Leachables Testing Services Market for Medical Devices, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.21 Extractables and Leachables Testing Services Market for Single Use Systems and Processing Equipment, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.22 Extractables and Leachables Testing Services Market for Other Components, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.23 Extractables and Leachables Testing Services Market: Distribution by Type of Technique Used

Table 23.24 Extractables and Leachables Testing Services Market for Chromatography, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.25 Extractables and Leachables Testing Services Market for Spectroscopy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.26 Extractables and Leachables Testing Services Market for Other Techniques, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.27 Extractables and Leachables Testing Services Market: Distribution by Company Size

Table 23.28 Extractables and Leachables Testing Services Market for Large Companies, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.29 Extractables and Leachables Testing Services Market for Mid-Sized Companies, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.30 Extractables and Leachables Testing Services Market for Small Companies, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.31 Extractables and Leachables Testing Services Market: Distribution by Application

Table 23.32 Extractables and Leachables Testing Services Market for Parenteral Drug Products, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.33 Extractables and Leachables Testing Services Market for Inhalation Drug Products, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.34 Extractables and Leachables Testing Services Market for Oral Solutions and Suspensions, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.35 Extractables and Leachables Testing Services Market in North America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.36 Extractables and Leachables Testing Services Market in the US, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.37 Extractables and Leachables Testing Services Market in Canada, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.38 Extractables and Leachables Testing Services Market in Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.39 Extractables and Leachables Testing Services Market in Germany, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.40 Extractables and Leachables Testing Services Market in Italy, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.41 Extractables and Leachables Testing Services Market in France, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.42 Extractables and Leachables Testing Services Market in the UK, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.43 Extractables and Leachables Testing Services Market in Spain, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.44 Extractables and Leachables Testing Services Market in Rest of Europe, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.45 Extractables and Leachables Testing Services Market in Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.46 Extractables and Leachables Testing Services Market in India, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.47 Extractables and Leachables Testing Services Market in China, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.48 Extractables and Leachables Testing Services Market in Japan, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.49 Extractables and Leachables Testing Services Market in Rest of Asia-Pacific, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.50 Extractables and Leachables Testing Services Market in Latin America, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.51 Extractables and Leachables Testing Services Market in Brazil, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.52 Extractables and Leachables Testing Services Market in Argentina, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.53 Extractables and Leachables Testing Services Market in Middle East and Africa, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.54 Extractables and Leachables Testing Services Market in South Africa, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.55 Extractables and Leachables Testing Services Market in Bahrain, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.56 Extractables and Leachables Testing Services Market in Saudi Arabia, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Table 23.57 Extractables and Leachables Testing Services Market in Israel, Historical Trends (Since 2023) and Forecasted Estimates (Till 2035) (USD Million)

Extractables and Leachables Testing Market 2nd Edition, 2026 to 2035